Previous close | 1.4000 |
Open | 1.4400 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's range | 1.4200 - 1.4500 |
52-week range | 1.1800 - 6.1000 |
Volume | |
Avg. volume | 8,649 |
Market cap | 25.489M |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | 28.80 |
EPS (TTM) | 0.0500 |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 04 July 2022 |
1y target est | 5.60 |
PARIS, April 02, 2024--Regulatory News: Groupe Berkem (Paris:ALKEM):
BLANQUEFORT, France, February 06, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 – Ticker: ALKEM), today announces its consolidated 2023 full-year revenue, as at December 31, 2023.
BLANQUEFORT, France & VERNIER, Switzerland, February 06, 2024--Regulatory News: Groupe Berkem, a leading player in bio-based chemistry (ISIN code: FR00140069V2 - Ticker: ALKEM), today announced the signature of a definitive agreement with Givaudan, world leader in the creation of flavors and fragrances (ISIN code: CH0010645932 - Ticker: GIVN), concerning the acquisition of Naturex Iberian Partners (Givaudan's industrial site in Valencia - Spain).